NIH-funded research Fellowship grant

Understanding how certain DNA-binding domains affect chromatin remodeling in cells

Official title: Defining the roles for the sequence-non-specific DNA-binding domains in mammalian SWI/SNF chromatin remodeling complex assembly and function

Funded at Harvard University · NIH-10901266 · Data updated 2026-11-12

This study is looking at how certain parts of a protein complex that helps control gene activity work together, especially in relation to human cancers and brain development issues, to better understand how changes in these proteins can lead to diseases.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionHarvard University
NIH-funded
Lab location1 site (Cambridge, United States)
Project startJuly 1, 2024
Project endJune 30, 2027
Funding year2024
Award (this year)$41,656
NIH project number1F31CA290929-01
Project IDNIH-10901266 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with mutations in SWI/SNF complex genes, particularly those affected by specific cancers or neurodevelopmental disorders.

Less likely to help

Patients without mutations in the SWI/SNF complex genes or those not affected by related conditions may not benefit from this research.

What this research studies

This research investigates the roles of specific DNA-binding domains within the mammalian SWI/SNF chromatin remodeling complexes, which are crucial for regulating gene expression and chromatin accessibility. The study will explore how these domains contribute to the assembly and function of these complexes, particularly in the context of human cancers and neurodevelopmental disorders. By using advanced techniques to analyze these interactions in human cells, the research aims to uncover the mechanisms behind mutations that affect these complexes and their implications for disease.

Why it matters

Potential benefit: If successful, this research could lead to new insights into the genetic causes of certain cancers and neurodevelopmental disorders, potentially guiding future therapeutic strategies.

How similar studies have gone: Previous research has shown that understanding chromatin remodeling complexes can lead to significant advancements in cancer treatment, indicating that this approach has potential for success.

Where this research is happening

  • Harvard University
    Cambridge, United States
    Active

Researchers

  • Principal investigator: Lieberman, Whitney Kate — Harvard University
  • Study coordinator: Lieberman, Whitney Kate

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.